EVIDENCE LIBRARY
Emergency Department Loxapine Study Reported Less Benzodiazepine Rescue Use in a Selected Group
A retrospective agitation study associated inhaled loxapine with less rescue benzodiazepine use. Clinician selection of patients limits a causal comparison with injectable antipsychotic strategies.
A retrospective agitation study associated inhaled loxapine with less rescue benzodiazepine use. Clinician selection of patients limits a causal comparison with injectable antipsychotic strategies.
The observed outcomes
Patients receiving inhaled loxapine had additional benzodiazepine use in 35.2% of cases versus 65.1% among controls receiving haloperidol or ziprasidone. Restraint use and time to medical clearance also differed.
These outcomes describe the entire care pathway, including the initial treatment choice and subsequent decisions about rescue medication.
The selection problem
The institution did not routinely use a standardized agitation-severity scale to guide drug choice. Patients willing and able to cooperate with inhaled treatment may have differed from those receiving other agents.
The study therefore does not establish that loxapine alone caused the lower benzodiazepine requirement. Rescue use also depends on staff judgment and treatment thresholds. When comparing cases, retain initial severity, cooperation, route feasibility, co-exposures, and timing. A lower rescue-medication rate should not be converted into proof of equivalent safety or efficacy for every agitated patient.
Source paper
Original analysis of the supplied journal article, identified as PMC6426345.